Patcos Cosmetics (India) Private Limited – FDA 483, Jul 18, 2025
Patcos Cosmetics (India) Private Limited, an OTC drug manufacturer in Daman, India, was cited for 17 observations during an FDA inspection. Key issues include severe data integrity concerns with altered laboratory records and torn pages, a dysfunctional quality control unit, lack of CGMP training, unvalidated analytical methods and manufacturing processes, and inadequate facility maintenance. Many of these issues were repeat observations from a previous 2023 inspection, indicating systemic and persistent non-compliance with good manufacturing practices.
ID · fb84808f-8282-40b9-b397-fe54f094d85e
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.